Receiving a Stage II lung cancer diagnosis marks the beginning of a highly focused effort to treat and manage your disease. At this stage, the cancer remains localized but requires a precise approach. This page will help you understand what a Stage II non-small cell lung cancer (NSCLC) diagnosis means, the diagnostic tests used to confirm your specific details, and how biomarker testing help your medical team customize your care path.
A Stage II diagnosis generally means the tumor is somewhat larger than in Stage I, or that cancer cells have reached specific, nearby lymph nodes on the same side of the chest. In this section, we will break down how doctors define Stage II subcategories and what this localized classification means for your immediate treatment outlook.
Click here to watch the American Cancer Society's videos on staging. Click here for more information about lung cancer staging.Before final treatment decisions are made, your healthcare team needs complete clarity. These videos detail the diagnostic roadmap, explaining why your doctors look closely at lung capacity, evaluate vital lymph nodes, and utilize surgical insights to ensure your diagnosis is mapped out before treatment begins.
Please click the boxes below to watch the videos.
Understanding a tumor means looking at its unique genetic behavior. In these videos, cancer experts cover biomarker and molecular testing, critical tools that search for specific cellular mutations driving the cancer's growth.
